Are there any side effects of Biktarvy? What should I pay attention to before use?

Biktarvy is a compound antiviral drug used to treat HIV infection, consisting of bictegra tablets vir), emtricitabine (emtricitabine) and tenofovir alafenamide (tenofovir Alafenamide (abbreviated as TAF) consists of three ingredients. As a third-generation integrase inhibitor combination regimen, Bituvi has the advantages of convenience, high drug resistance barrier, and fewer adverse reactions. It is widely used in treatment-naïve and stable HIV-infected patients around the world. However, like all drugs, Bitovil may also produce certain side effects during use. Patients must fully understand it before use and carry out standardized treatment under the guidance of a doctor.

First of all, judging from clinical trials and real-world data, Bituvi is generally well tolerated, and the vast majority of side effects are mild to moderate and short-lived. Common adverse reactions mainly include gastrointestinal reactions, such as nausea, diarrhea, bloating, headache, insomnia, fatigue, etc. Some patients may experience loss of appetite or weight changes, which are usually noticeable early on in the medication, but most people can gradually adapt to it over weeks to months. In addition, a small number of people have reported mood swings or anxiety, especially those with a history of nervous system sensitivity, and need to be closely monitored.

In terms of liver and kidney function, Bituvir has better safety than previous generations of HIV drugs. In particular, the TAF component has a significantly smaller impact on kidney function and bone density than TDF (tenofovir disoproxil). Nonetheless, it is still recommended to check renal function indicators (such as creatinine clearance) and liver function before use. If there is moderate to severe renal insufficiency or hepatitis B infection, it should be used with special caution. Since emtricitabine and TAF in Bituvi also have anti-hepatitis B virus activity, if the patient also suffers from hepatitis B, sudden discontinuation of the drug may cause hepatitis B to rebound or worsen. Therefore, such patients need to fully communicate with their doctor before taking the drug and continue to follow up on their liver function after stopping the drug.

In addition, Bituwei also has clear requirements on the way of taking it. It is usually recommended to take it once a day, regardless of food intake, but it should be maintained regularly. Caution should be exercised when combined with other drugs, especially antacids containing magnesium, aluminum, and calcium, certain anti-epileptic drugs, and rifampicin drugs that may affect the blood concentration of bictinol in Bitovil, thereby reducing the efficacy or increasing the risk of side effects. To avoid drug interactions, patients should proactively report all prescription drugs, over-the-counter drugs, and supplements they are taking to their doctors.

In short, Bitovil is a new generation of high-efficiency, low-toxicity HIVHIVTherapeutic drugs have relatively few side effects, are easy to use and have stable effects. Although some patients may experience mild discomfort in the early stages, under the guidance of a doctor, most people can adapt smoothly and benefit long-term. Before use, a comprehensive physical examination should be performed, potential complications and drug interaction risks should be understood, and good medication compliance should be maintained to ensure maximum treatment effect and minimize side effects. If persistent discomfort or adverse reactions occur during medication, you should seek medical advice promptly to adjust the treatment plan.

Reference materials:https://www.biktarvy.com/